nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezogabine—UGT1A3—Ezetimibe—atherosclerosis	0.176	0.217	CbGbCtD
Ezogabine—UGT1A3—Simvastatin—atherosclerosis	0.164	0.201	CbGbCtD
Ezogabine—UGT1A3—Lovastatin—atherosclerosis	0.16	0.197	CbGbCtD
Ezogabine—UGT1A1—Ezetimibe—atherosclerosis	0.11	0.135	CbGbCtD
Ezogabine—UGT1A1—Simvastatin—atherosclerosis	0.102	0.126	CbGbCtD
Ezogabine—UGT1A1—Lovastatin—atherosclerosis	0.1	0.123	CbGbCtD
Ezogabine—Raised liver function tests—Niacin—atherosclerosis	0.00316	0.0261	CcSEcCtD
Ezogabine—Raised liver function tests—Pravastatin—atherosclerosis	0.00311	0.0257	CcSEcCtD
Ezogabine—Memory impairment—Rosuvastatin—atherosclerosis	0.00255	0.0211	CcSEcCtD
Ezogabine—Memory impairment—Lovastatin—atherosclerosis	0.00216	0.0178	CcSEcCtD
Ezogabine—Hypokinesia—Niacin—atherosclerosis	0.00216	0.0178	CcSEcCtD
Ezogabine—Memory impairment—Ezetimibe—atherosclerosis	0.00212	0.0175	CcSEcCtD
Ezogabine—Memory impairment—Simvastatin—atherosclerosis	0.00202	0.0167	CcSEcCtD
Ezogabine—Memory impairment—Pravastatin—atherosclerosis	0.00183	0.0151	CcSEcCtD
Ezogabine—Skin discolouration—Niacin—atherosclerosis	0.00162	0.0133	CcSEcCtD
Ezogabine—Amnesia—Rosuvastatin—atherosclerosis	0.00155	0.0128	CcSEcCtD
Ezogabine—Amnesia—Lovastatin—atherosclerosis	0.00131	0.0108	CcSEcCtD
Ezogabine—Amnesia—Ezetimibe—atherosclerosis	0.00129	0.0106	CcSEcCtD
Ezogabine—Influenza—Rosuvastatin—atherosclerosis	0.00126	0.0104	CcSEcCtD
Ezogabine—Amnesia—Simvastatin—atherosclerosis	0.00123	0.0101	CcSEcCtD
Ezogabine—Liver function test abnormal—Ezetimibe—atherosclerosis	0.00112	0.00921	CcSEcCtD
Ezogabine—Amnesia—Pravastatin—atherosclerosis	0.00111	0.00915	CcSEcCtD
Ezogabine—Haematuria—Rosuvastatin—atherosclerosis	0.00107	0.00881	CcSEcCtD
Ezogabine—Influenza—Lovastatin—atherosclerosis	0.00107	0.00879	CcSEcCtD
Ezogabine—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.00106	0.00874	CcSEcCtD
Ezogabine—Influenza—Ezetimibe—atherosclerosis	0.00105	0.00862	CcSEcCtD
Ezogabine—Diplopia—Pravastatin—atherosclerosis	0.00104	0.0086	CcSEcCtD
Ezogabine—Urinary retention—Niacin—atherosclerosis	0.00101	0.0083	CcSEcCtD
Ezogabine—Liver function test abnormal—Niacin—atherosclerosis	0.000978	0.00806	CcSEcCtD
Ezogabine—Liver function test abnormal—Pravastatin—atherosclerosis	0.000963	0.00794	CcSEcCtD
Ezogabine—Infestation NOS—Ezetimibe—atherosclerosis	0.000932	0.00768	CcSEcCtD
Ezogabine—Infestation—Ezetimibe—atherosclerosis	0.000932	0.00768	CcSEcCtD
Ezogabine—Influenza—Niacin—atherosclerosis	0.000915	0.00755	CcSEcCtD
Ezogabine—Dysphagia—Niacin—atherosclerosis	0.000915	0.00755	CcSEcCtD
Ezogabine—Influenza—Pravastatin—atherosclerosis	0.000901	0.00743	CcSEcCtD
Ezogabine—Mental disorder—Rosuvastatin—atherosclerosis	0.000882	0.00727	CcSEcCtD
Ezogabine—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.000881	0.00727	CcSEcCtD
Ezogabine—Dysuria—Pravastatin—atherosclerosis	0.000843	0.00695	CcSEcCtD
Ezogabine—Oedema peripheral—Ezetimibe—atherosclerosis	0.000824	0.0068	CcSEcCtD
Ezogabine—Weight increased—Pravastatin—atherosclerosis	0.00082	0.00676	CcSEcCtD
Ezogabine—Alopecia—Lovastatin—atherosclerosis	0.000754	0.00621	CcSEcCtD
Ezogabine—Alopecia—Ezetimibe—atherosclerosis	0.000739	0.0061	CcSEcCtD
Ezogabine—Mental disorder—Ezetimibe—atherosclerosis	0.000733	0.00604	CcSEcCtD
Ezogabine—Malnutrition—Ezetimibe—atherosclerosis	0.000728	0.00601	CcSEcCtD
Ezogabine—Oedema peripheral—Niacin—atherosclerosis	0.000722	0.00595	CcSEcCtD
Ezogabine—Confusional state—Rosuvastatin—atherosclerosis	0.000721	0.00595	CcSEcCtD
Ezogabine—Muscle spasms—Lovastatin—atherosclerosis	0.000714	0.00589	CcSEcCtD
Ezogabine—Infection—Rosuvastatin—atherosclerosis	0.00071	0.00586	CcSEcCtD
Ezogabine—Visual impairment—Niacin—atherosclerosis	0.000706	0.00582	CcSEcCtD
Ezogabine—Alopecia—Simvastatin—atherosclerosis	0.000705	0.00581	CcSEcCtD
Ezogabine—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000701	0.00578	CcSEcCtD
Ezogabine—Muscle spasms—Ezetimibe—atherosclerosis	0.0007	0.00577	CcSEcCtD
Ezogabine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.0007	0.00577	CcSEcCtD
Ezogabine—Vision blurred—Lovastatin—atherosclerosis	0.0007	0.00577	CcSEcCtD
Ezogabine—Mental disorder—Simvastatin—atherosclerosis	0.000699	0.00576	CcSEcCtD
Ezogabine—Tremor—Lovastatin—atherosclerosis	0.000696	0.00574	CcSEcCtD
Ezogabine—Visual impairment—Pravastatin—atherosclerosis	0.000695	0.00573	CcSEcCtD
Ezogabine—Ill-defined disorder—Lovastatin—atherosclerosis	0.000689	0.00568	CcSEcCtD
Ezogabine—Eye disorder—Niacin—atherosclerosis	0.000685	0.00565	CcSEcCtD
Ezogabine—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000676	0.00557	CcSEcCtD
Ezogabine—Malaise—Lovastatin—atherosclerosis	0.00067	0.00552	CcSEcCtD
Ezogabine—Muscle spasms—Simvastatin—atherosclerosis	0.000668	0.00551	CcSEcCtD
Ezogabine—Vertigo—Lovastatin—atherosclerosis	0.000667	0.0055	CcSEcCtD
Ezogabine—Leukopenia—Lovastatin—atherosclerosis	0.000665	0.00548	CcSEcCtD
Ezogabine—Malaise—Ezetimibe—atherosclerosis	0.000657	0.00542	CcSEcCtD
Ezogabine—Vision blurred—Simvastatin—atherosclerosis	0.000655	0.0054	CcSEcCtD
Ezogabine—Tremor—Simvastatin—atherosclerosis	0.000651	0.00537	CcSEcCtD
Ezogabine—Alopecia—Niacin—atherosclerosis	0.000647	0.00534	CcSEcCtD
Ezogabine—Ill-defined disorder—Simvastatin—atherosclerosis	0.000644	0.00531	CcSEcCtD
Ezogabine—Paraesthesia—Rosuvastatin—atherosclerosis	0.000642	0.00529	CcSEcCtD
Ezogabine—Malnutrition—Niacin—atherosclerosis	0.000638	0.00526	CcSEcCtD
Ezogabine—Alopecia—Pravastatin—atherosclerosis	0.000637	0.00526	CcSEcCtD
Ezogabine—Anxiety—Lovastatin—atherosclerosis	0.00063	0.00519	CcSEcCtD
Ezogabine—Dyspepsia—Rosuvastatin—atherosclerosis	0.00063	0.00519	CcSEcCtD
Ezogabine—Malaise—Simvastatin—atherosclerosis	0.000626	0.00516	CcSEcCtD
Ezogabine—Discomfort—Lovastatin—atherosclerosis	0.000625	0.00515	CcSEcCtD
Ezogabine—Vertigo—Simvastatin—atherosclerosis	0.000624	0.00515	CcSEcCtD
Ezogabine—Leukopenia—Simvastatin—atherosclerosis	0.000622	0.00513	CcSEcCtD
Ezogabine—Dry mouth—Lovastatin—atherosclerosis	0.000618	0.0051	CcSEcCtD
Ezogabine—Muscle spasms—Niacin—atherosclerosis	0.000613	0.00506	CcSEcCtD
Ezogabine—Discomfort—Ezetimibe—atherosclerosis	0.000613	0.00505	CcSEcCtD
Ezogabine—Constipation—Rosuvastatin—atherosclerosis	0.000612	0.00504	CcSEcCtD
Ezogabine—Confusional state—Lovastatin—atherosclerosis	0.000611	0.00504	CcSEcCtD
Ezogabine—Dry mouth—Ezetimibe—atherosclerosis	0.000606	0.005	CcSEcCtD
Ezogabine—Muscle spasms—Pravastatin—atherosclerosis	0.000604	0.00498	CcSEcCtD
Ezogabine—Infection—Lovastatin—atherosclerosis	0.000602	0.00496	CcSEcCtD
Ezogabine—Vision blurred—Niacin—atherosclerosis	0.000601	0.00496	CcSEcCtD
Ezogabine—Confusional state—Ezetimibe—atherosclerosis	0.000599	0.00494	CcSEcCtD
Ezogabine—Thrombocytopenia—Lovastatin—atherosclerosis	0.000593	0.00489	CcSEcCtD
Ezogabine—Vision blurred—Pravastatin—atherosclerosis	0.000592	0.00488	CcSEcCtD
Ezogabine—Infection—Ezetimibe—atherosclerosis	0.000591	0.00487	CcSEcCtD
Ezogabine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000589	0.00486	CcSEcCtD
Ezogabine—Anxiety—Simvastatin—atherosclerosis	0.000589	0.00486	CcSEcCtD
Ezogabine—Tremor—Pravastatin—atherosclerosis	0.000588	0.00485	CcSEcCtD
Ezogabine—Discomfort—Simvastatin—atherosclerosis	0.000584	0.00482	CcSEcCtD
Ezogabine—Nervous system disorder—Ezetimibe—atherosclerosis	0.000583	0.00481	CcSEcCtD
Ezogabine—Ill-defined disorder—Pravastatin—atherosclerosis	0.000583	0.0048	CcSEcCtD
Ezogabine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000582	0.0048	CcSEcCtD
Ezogabine—Vertigo—Niacin—atherosclerosis	0.000573	0.00472	CcSEcCtD
Ezogabine—Syncope—Niacin—atherosclerosis	0.000572	0.00472	CcSEcCtD
Ezogabine—Confusional state—Simvastatin—atherosclerosis	0.000572	0.00471	CcSEcCtD
Ezogabine—Leukopenia—Niacin—atherosclerosis	0.000571	0.00471	CcSEcCtD
Ezogabine—Malaise—Pravastatin—atherosclerosis	0.000566	0.00467	CcSEcCtD
Ezogabine—Vertigo—Pravastatin—atherosclerosis	0.000564	0.00465	CcSEcCtD
Ezogabine—Infection—Simvastatin—atherosclerosis	0.000563	0.00464	CcSEcCtD
Ezogabine—Leukopenia—Pravastatin—atherosclerosis	0.000562	0.00463	CcSEcCtD
Ezogabine—Loss of consciousness—Niacin—atherosclerosis	0.000561	0.00462	CcSEcCtD
Ezogabine—Thrombocytopenia—Simvastatin—atherosclerosis	0.000555	0.00458	CcSEcCtD
Ezogabine—Paraesthesia—Lovastatin—atherosclerosis	0.000544	0.00449	CcSEcCtD
Ezogabine—Dyspnoea—Lovastatin—atherosclerosis	0.00054	0.00445	CcSEcCtD
Ezogabine—Paraesthesia—Ezetimibe—atherosclerosis	0.000534	0.0044	CcSEcCtD
Ezogabine—Dyspepsia—Lovastatin—atherosclerosis	0.000533	0.0044	CcSEcCtD
Ezogabine—Anxiety—Pravastatin—atherosclerosis	0.000533	0.00439	CcSEcCtD
Ezogabine—Dry mouth—Niacin—atherosclerosis	0.000531	0.00438	CcSEcCtD
Ezogabine—Dyspnoea—Ezetimibe—atherosclerosis	0.00053	0.00437	CcSEcCtD
Ezogabine—Discomfort—Pravastatin—atherosclerosis	0.000528	0.00435	CcSEcCtD
Ezogabine—Dyspepsia—Ezetimibe—atherosclerosis	0.000523	0.00431	CcSEcCtD
Ezogabine—Fatigue—Lovastatin—atherosclerosis	0.000523	0.00431	CcSEcCtD
Ezogabine—Constipation—Lovastatin—atherosclerosis	0.000518	0.00427	CcSEcCtD
Ezogabine—Confusional state—Pravastatin—atherosclerosis	0.000517	0.00426	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000513	0.00423	CcSEcCtD
Ezogabine—Asthenia—Rosuvastatin—atherosclerosis	0.000513	0.00423	CcSEcCtD
Ezogabine—Fatigue—Ezetimibe—atherosclerosis	0.000513	0.00423	CcSEcCtD
Ezogabine—Shock—Niacin—atherosclerosis	0.000512	0.00422	CcSEcCtD
Ezogabine—Infection—Pravastatin—atherosclerosis	0.000509	0.0042	CcSEcCtD
Ezogabine—Paraesthesia—Simvastatin—atherosclerosis	0.000509	0.0042	CcSEcCtD
Ezogabine—Constipation—Ezetimibe—atherosclerosis	0.000508	0.00419	CcSEcCtD
Ezogabine—Dyspnoea—Simvastatin—atherosclerosis	0.000505	0.00417	CcSEcCtD
Ezogabine—Hyperhidrosis—Niacin—atherosclerosis	0.000503	0.00415	CcSEcCtD
Ezogabine—Thrombocytopenia—Pravastatin—atherosclerosis	0.000502	0.00414	CcSEcCtD
Ezogabine—Feeling abnormal—Lovastatin—atherosclerosis	0.000499	0.00412	CcSEcCtD
Ezogabine—Dyspepsia—Simvastatin—atherosclerosis	0.000499	0.00411	CcSEcCtD
Ezogabine—Hyperhidrosis—Pravastatin—atherosclerosis	0.000495	0.00408	CcSEcCtD
Ezogabine—Feeling abnormal—Ezetimibe—atherosclerosis	0.00049	0.00404	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000489	0.00404	CcSEcCtD
Ezogabine—Fatigue—Simvastatin—atherosclerosis	0.000489	0.00403	CcSEcCtD
Ezogabine—Constipation—Simvastatin—atherosclerosis	0.000485	0.004	CcSEcCtD
Ezogabine—Dizziness—Rosuvastatin—atherosclerosis	0.000473	0.0039	CcSEcCtD
Ezogabine—Paraesthesia—Niacin—atherosclerosis	0.000467	0.00385	CcSEcCtD
Ezogabine—Feeling abnormal—Simvastatin—atherosclerosis	0.000467	0.00385	CcSEcCtD
Ezogabine—Dyspnoea—Niacin—atherosclerosis	0.000464	0.00383	CcSEcCtD
Ezogabine—Somnolence—Niacin—atherosclerosis	0.000463	0.00382	CcSEcCtD
Ezogabine—Paraesthesia—Pravastatin—atherosclerosis	0.00046	0.00379	CcSEcCtD
Ezogabine—Dyspepsia—Niacin—atherosclerosis	0.000458	0.00378	CcSEcCtD
Ezogabine—Dyspnoea—Pravastatin—atherosclerosis	0.000457	0.00377	CcSEcCtD
Ezogabine—Dyspepsia—Pravastatin—atherosclerosis	0.000451	0.00372	CcSEcCtD
Ezogabine—Rash—Rosuvastatin—atherosclerosis	0.000451	0.00372	CcSEcCtD
Ezogabine—Dermatitis—Rosuvastatin—atherosclerosis	0.000451	0.00371	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Niacin—atherosclerosis	0.000449	0.00371	CcSEcCtD
Ezogabine—Fatigue—Pravastatin—atherosclerosis	0.000442	0.00364	CcSEcCtD
Ezogabine—Constipation—Pravastatin—atherosclerosis	0.000438	0.00361	CcSEcCtD
Ezogabine—Asthenia—Lovastatin—atherosclerosis	0.000435	0.00359	CcSEcCtD
Ezogabine—Asthenia—Ezetimibe—atherosclerosis	0.000427	0.00352	CcSEcCtD
Ezogabine—Nausea—Rosuvastatin—atherosclerosis	0.000425	0.0035	CcSEcCtD
Ezogabine—Feeling abnormal—Pravastatin—atherosclerosis	0.000422	0.00348	CcSEcCtD
Ezogabine—Asthenia—Simvastatin—atherosclerosis	0.000407	0.00335	CcSEcCtD
Ezogabine—Dizziness—Lovastatin—atherosclerosis	0.000401	0.0033	CcSEcCtD
Ezogabine—Dizziness—Ezetimibe—atherosclerosis	0.000393	0.00324	CcSEcCtD
Ezogabine—Rash—Lovastatin—atherosclerosis	0.000382	0.00315	CcSEcCtD
Ezogabine—Dermatitis—Lovastatin—atherosclerosis	0.000382	0.00315	CcSEcCtD
Ezogabine—Dizziness—Simvastatin—atherosclerosis	0.000375	0.00309	CcSEcCtD
Ezogabine—Rash—Ezetimibe—atherosclerosis	0.000375	0.00309	CcSEcCtD
Ezogabine—Dermatitis—Ezetimibe—atherosclerosis	0.000374	0.00309	CcSEcCtD
Ezogabine—Asthenia—Niacin—atherosclerosis	0.000373	0.00308	CcSEcCtD
Ezogabine—Asthenia—Pravastatin—atherosclerosis	0.000368	0.00303	CcSEcCtD
Ezogabine—Nausea—Lovastatin—atherosclerosis	0.00036	0.00297	CcSEcCtD
Ezogabine—Rash—Simvastatin—atherosclerosis	0.000357	0.00295	CcSEcCtD
Ezogabine—Dermatitis—Simvastatin—atherosclerosis	0.000357	0.00294	CcSEcCtD
Ezogabine—Nausea—Ezetimibe—atherosclerosis	0.000353	0.00291	CcSEcCtD
Ezogabine—Dizziness—Niacin—atherosclerosis	0.000344	0.00284	CcSEcCtD
Ezogabine—Dizziness—Pravastatin—atherosclerosis	0.000339	0.00279	CcSEcCtD
Ezogabine—Nausea—Simvastatin—atherosclerosis	0.000337	0.00278	CcSEcCtD
Ezogabine—Rash—Niacin—atherosclerosis	0.000328	0.00271	CcSEcCtD
Ezogabine—Dermatitis—Niacin—atherosclerosis	0.000328	0.0027	CcSEcCtD
Ezogabine—Rash—Pravastatin—atherosclerosis	0.000323	0.00266	CcSEcCtD
Ezogabine—Dermatitis—Pravastatin—atherosclerosis	0.000323	0.00266	CcSEcCtD
Ezogabine—Nausea—Niacin—atherosclerosis	0.000309	0.00255	CcSEcCtD
Ezogabine—Nausea—Pravastatin—atherosclerosis	0.000304	0.00251	CcSEcCtD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	4.94e-05	0.000751	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ALOX5—atherosclerosis	4.93e-05	0.000749	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—HMOX1—atherosclerosis	4.84e-05	0.000735	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PLA2G2A—atherosclerosis	4.82e-05	0.000732	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ALOX15—atherosclerosis	4.82e-05	0.000732	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—APOA2—atherosclerosis	4.82e-05	0.000732	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ALOX5AP—atherosclerosis	4.82e-05	0.000732	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ABCG5—atherosclerosis	4.76e-05	0.000723	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—VEGFA—atherosclerosis	4.73e-05	0.000719	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—VEGFA—atherosclerosis	4.73e-05	0.000719	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PLTP—atherosclerosis	4.71e-05	0.000716	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—STAT3—atherosclerosis	4.69e-05	0.000712	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—STAT3—atherosclerosis	4.69e-05	0.000712	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—APOB—atherosclerosis	4.63e-05	0.000704	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—LPA—atherosclerosis	4.6e-05	0.000698	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—IL6—atherosclerosis	4.59e-05	0.000697	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—IL6—atherosclerosis	4.59e-05	0.000697	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—GSTM1—atherosclerosis	4.51e-05	0.000685	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—MAPK3—atherosclerosis	4.48e-05	0.00068	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—MAPK3—atherosclerosis	4.48e-05	0.00068	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—BGN—atherosclerosis	4.45e-05	0.000676	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—LPL—atherosclerosis	4.43e-05	0.000672	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—NAMPT—atherosclerosis	4.42e-05	0.000671	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—APOA5—atherosclerosis	4.41e-05	0.000669	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	4.41e-05	0.000669	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—LIPC—atherosclerosis	4.39e-05	0.000667	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—APOC3—atherosclerosis	4.37e-05	0.000663	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—TGFB1—atherosclerosis	4.34e-05	0.00066	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—TGFB1—atherosclerosis	4.34e-05	0.00066	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—LDLR—atherosclerosis	4.34e-05	0.000659	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—GPX1—atherosclerosis	4.32e-05	0.000656	CbGpPWpGaD
Ezogabine—UGT1A1—NRF2 pathway—TGFB1—atherosclerosis	4.26e-05	0.000647	CbGpPWpGaD
Ezogabine—UGT1A9—NRF2 pathway—TGFB1—atherosclerosis	4.26e-05	0.000647	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PLA2G1B—atherosclerosis	4.24e-05	0.000644	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CETP—atherosclerosis	4.24e-05	0.000644	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—CD36—atherosclerosis	4.21e-05	0.000638	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ABCG1—atherosclerosis	4.19e-05	0.000636	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ABCG1—atherosclerosis	4.19e-05	0.000636	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ALOX5—atherosclerosis	4.1e-05	0.000622	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ABCG8—atherosclerosis	4.09e-05	0.000621	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—LTA4H—atherosclerosis	4.09e-05	0.000621	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—SCARB1—atherosclerosis	4.06e-05	0.000616	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—TNF—atherosclerosis	4.06e-05	0.000616	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—TNF—atherosclerosis	4.06e-05	0.000616	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—MTHFR—atherosclerosis	3.98e-05	0.000605	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—FABP4—atherosclerosis	3.94e-05	0.000598	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—LCAT—atherosclerosis	3.94e-05	0.000598	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—LCAT—atherosclerosis	3.94e-05	0.000598	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—FABP4—atherosclerosis	3.94e-05	0.000598	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PPARA—atherosclerosis	3.91e-05	0.000594	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—APOA4—atherosclerosis	3.87e-05	0.000587	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—APOA4—atherosclerosis	3.87e-05	0.000587	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—HMGCR—atherosclerosis	3.83e-05	0.000582	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CYP7A1—atherosclerosis	3.8e-05	0.000577	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CYP7A1—atherosclerosis	3.8e-05	0.000577	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—AGT—atherosclerosis	3.79e-05	0.000575	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—APOE—atherosclerosis	3.71e-05	0.000563	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—NAMPT—atherosclerosis	3.68e-05	0.000558	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—CAV1—atherosclerosis	3.68e-05	0.000558	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—APOA1—atherosclerosis	3.67e-05	0.000557	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—LIPC—atherosclerosis	3.65e-05	0.000555	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—APOC3—atherosclerosis	3.63e-05	0.000551	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	3.62e-05	0.00055	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—LDLR—atherosclerosis	3.61e-05	0.000548	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CETP—atherosclerosis	3.52e-05	0.000535	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CYP27A1—atherosclerosis	3.51e-05	0.000533	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CYP27A1—atherosclerosis	3.51e-05	0.000533	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	3.46e-05	0.000525	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ABCA1—atherosclerosis	3.42e-05	0.000519	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—SCARB1—atherosclerosis	3.37e-05	0.000512	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	3.37e-05	0.000512	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PIK3CG—atherosclerosis	3.35e-05	0.000508	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ALOX15—atherosclerosis	3.33e-05	0.000506	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PLA2G2A—atherosclerosis	3.33e-05	0.000506	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—APOA2—atherosclerosis	3.33e-05	0.000506	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ALOX15—atherosclerosis	3.33e-05	0.000506	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PLA2G2A—atherosclerosis	3.33e-05	0.000506	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ALOX5AP—atherosclerosis	3.33e-05	0.000506	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—APOA2—atherosclerosis	3.33e-05	0.000506	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ALOX5AP—atherosclerosis	3.33e-05	0.000506	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ABCG5—atherosclerosis	3.29e-05	0.000499	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ABCG5—atherosclerosis	3.29e-05	0.000499	CbGpPWpGaD
Ezogabine—CYP2A6—NRF2 pathway—TGFB1—atherosclerosis	3.29e-05	0.000499	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	3.29e-05	0.000499	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—IL6—atherosclerosis	3.27e-05	0.000497	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—IL6—atherosclerosis	3.27e-05	0.000497	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ABCG1—atherosclerosis	3.23e-05	0.000491	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PPARG—atherosclerosis	3.23e-05	0.000491	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—HMGCR—atherosclerosis	3.19e-05	0.000484	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—LPA—atherosclerosis	3.18e-05	0.000482	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—LPA—atherosclerosis	3.18e-05	0.000482	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—INS—atherosclerosis	3.17e-05	0.000481	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—BGN—atherosclerosis	3.08e-05	0.000467	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—BGN—atherosclerosis	3.08e-05	0.000467	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	3.05e-05	0.000464	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—APOA5—atherosclerosis	3.05e-05	0.000462	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—APOA5—atherosclerosis	3.05e-05	0.000462	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—FABP4—atherosclerosis	3.04e-05	0.000461	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—LCAT—atherosclerosis	3.04e-05	0.000461	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—AKT1—atherosclerosis	3.02e-05	0.000459	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—AKT1—atherosclerosis	3.02e-05	0.000459	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—APOA4—atherosclerosis	2.98e-05	0.000453	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	2.96e-05	0.000449	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—HMOX1—atherosclerosis	2.93e-05	0.000445	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PLA2G1B—atherosclerosis	2.93e-05	0.000445	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PLA2G1B—atherosclerosis	2.93e-05	0.000445	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CYP7A1—atherosclerosis	2.93e-05	0.000445	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—ALB—atherosclerosis	2.91e-05	0.000441	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	2.9e-05	0.00044	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	2.87e-05	0.000436	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	2.87e-05	0.000435	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ABCA1—atherosclerosis	2.84e-05	0.000431	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ALOX5—atherosclerosis	2.83e-05	0.00043	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ALOX5—atherosclerosis	2.83e-05	0.00043	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—APOB—atherosclerosis	2.81e-05	0.000426	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—NOS3—atherosclerosis	2.78e-05	0.000422	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—GSTM1—atherosclerosis	2.73e-05	0.000415	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CYP27A1—atherosclerosis	2.71e-05	0.000411	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—LPL—atherosclerosis	2.68e-05	0.000407	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—GPX1—atherosclerosis	2.62e-05	0.000397	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.62e-05	0.000397	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PLA2G2A—atherosclerosis	2.57e-05	0.00039	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—APOA2—atherosclerosis	2.57e-05	0.00039	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ALOX15—atherosclerosis	2.57e-05	0.00039	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ALOX5AP—atherosclerosis	2.57e-05	0.00039	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CD36—atherosclerosis	2.55e-05	0.000387	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PTGS2—atherosclerosis	2.54e-05	0.000386	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—NAMPT—atherosclerosis	2.54e-05	0.000386	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—NAMPT—atherosclerosis	2.54e-05	0.000386	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ABCG5—atherosclerosis	2.54e-05	0.000385	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.52e-05	0.000383	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—LIPC—atherosclerosis	2.52e-05	0.000383	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—LIPC—atherosclerosis	2.52e-05	0.000383	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—APOC3—atherosclerosis	2.51e-05	0.000381	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—APOC3—atherosclerosis	2.51e-05	0.000381	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—LDLR—atherosclerosis	2.49e-05	0.000378	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—LDLR—atherosclerosis	2.49e-05	0.000378	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—LPA—atherosclerosis	2.45e-05	0.000372	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—HMOX1—atherosclerosis	2.44e-05	0.00037	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CETP—atherosclerosis	2.43e-05	0.00037	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CETP—atherosclerosis	2.43e-05	0.00037	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—MTHFR—atherosclerosis	2.41e-05	0.000367	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—BGN—atherosclerosis	2.37e-05	0.00036	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PPARA—atherosclerosis	2.37e-05	0.00036	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—APOA5—atherosclerosis	2.35e-05	0.000356	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—APOB—atherosclerosis	2.33e-05	0.000354	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—SCARB1—atherosclerosis	2.33e-05	0.000354	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—SCARB1—atherosclerosis	2.33e-05	0.000354	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—AGT—atherosclerosis	2.29e-05	0.000348	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—GSTM1—atherosclerosis	2.27e-05	0.000345	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.27e-05	0.000345	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PLA2G1B—atherosclerosis	2.26e-05	0.000343	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—APOE—atherosclerosis	2.25e-05	0.000341	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—LPL—atherosclerosis	2.23e-05	0.000338	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CAV1—atherosclerosis	2.23e-05	0.000338	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—APOA1—atherosclerosis	2.22e-05	0.000337	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—HMGCR—atherosclerosis	2.2e-05	0.000334	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—HMGCR—atherosclerosis	2.2e-05	0.000334	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ALOX5—atherosclerosis	2.18e-05	0.000331	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—GPX1—atherosclerosis	2.17e-05	0.00033	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CD36—atherosclerosis	2.12e-05	0.000322	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PIK3CG—atherosclerosis	2.03e-05	0.000308	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—MTHFR—atherosclerosis	2.01e-05	0.000305	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.99e-05	0.000302	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PPARA—atherosclerosis	1.97e-05	0.000299	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ABCA1—atherosclerosis	1.96e-05	0.000298	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ABCA1—atherosclerosis	1.96e-05	0.000298	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PPARG—atherosclerosis	1.96e-05	0.000297	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—NAMPT—atherosclerosis	1.96e-05	0.000297	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—LIPC—atherosclerosis	1.95e-05	0.000295	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—APOC3—atherosclerosis	1.93e-05	0.000294	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—LDLR—atherosclerosis	1.92e-05	0.000292	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—INS—atherosclerosis	1.92e-05	0.000292	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—AGT—atherosclerosis	1.91e-05	0.00029	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CETP—atherosclerosis	1.88e-05	0.000285	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—APOE—atherosclerosis	1.87e-05	0.000284	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CAV1—atherosclerosis	1.85e-05	0.000281	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—APOA1—atherosclerosis	1.85e-05	0.00028	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—SCARB1—atherosclerosis	1.8e-05	0.000273	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ALB—atherosclerosis	1.76e-05	0.000267	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—HMGCR—atherosclerosis	1.7e-05	0.000258	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PIK3CG—atherosclerosis	1.69e-05	0.000256	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—NOS3—atherosclerosis	1.68e-05	0.000256	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—HMOX1—atherosclerosis	1.68e-05	0.000256	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—HMOX1—atherosclerosis	1.68e-05	0.000256	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PPARG—atherosclerosis	1.63e-05	0.000247	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—APOB—atherosclerosis	1.61e-05	0.000245	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—APOB—atherosclerosis	1.61e-05	0.000245	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—INS—atherosclerosis	1.6e-05	0.000242	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GSTM1—atherosclerosis	1.57e-05	0.000238	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GSTM1—atherosclerosis	1.57e-05	0.000238	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PTGS2—atherosclerosis	1.54e-05	0.000234	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—LPL—atherosclerosis	1.54e-05	0.000234	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—LPL—atherosclerosis	1.54e-05	0.000234	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ABCA1—atherosclerosis	1.51e-05	0.00023	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GPX1—atherosclerosis	1.5e-05	0.000228	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GPX1—atherosclerosis	1.5e-05	0.000228	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ALB—atherosclerosis	1.46e-05	0.000222	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CD36—atherosclerosis	1.46e-05	0.000222	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CD36—atherosclerosis	1.46e-05	0.000222	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—NOS3—atherosclerosis	1.4e-05	0.000213	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—MTHFR—atherosclerosis	1.39e-05	0.000211	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—MTHFR—atherosclerosis	1.39e-05	0.000211	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PPARA—atherosclerosis	1.36e-05	0.000207	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PPARA—atherosclerosis	1.36e-05	0.000207	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—AGT—atherosclerosis	1.32e-05	0.0002	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—AGT—atherosclerosis	1.32e-05	0.0002	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—HMOX1—atherosclerosis	1.3e-05	0.000197	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—APOE—atherosclerosis	1.29e-05	0.000196	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—APOE—atherosclerosis	1.29e-05	0.000196	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PTGS2—atherosclerosis	1.28e-05	0.000194	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CAV1—atherosclerosis	1.28e-05	0.000194	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CAV1—atherosclerosis	1.28e-05	0.000194	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—AKT1—atherosclerosis	1.28e-05	0.000194	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—APOA1—atherosclerosis	1.28e-05	0.000194	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—APOA1—atherosclerosis	1.28e-05	0.000194	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—APOB—atherosclerosis	1.24e-05	0.000189	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GSTM1—atherosclerosis	1.21e-05	0.000184	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—LPL—atherosclerosis	1.19e-05	0.00018	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PIK3CG—atherosclerosis	1.17e-05	0.000177	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PIK3CG—atherosclerosis	1.17e-05	0.000177	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GPX1—atherosclerosis	1.16e-05	0.000176	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CD36—atherosclerosis	1.13e-05	0.000171	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PPARG—atherosclerosis	1.12e-05	0.000171	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PPARG—atherosclerosis	1.12e-05	0.000171	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—INS—atherosclerosis	1.1e-05	0.000167	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—INS—atherosclerosis	1.1e-05	0.000167	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—MTHFR—atherosclerosis	1.07e-05	0.000162	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PPARA—atherosclerosis	1.05e-05	0.000159	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—AGT—atherosclerosis	1.02e-05	0.000154	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ALB—atherosclerosis	1.01e-05	0.000154	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ALB—atherosclerosis	1.01e-05	0.000154	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—APOE—atherosclerosis	9.95e-06	0.000151	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CAV1—atherosclerosis	9.86e-06	0.00015	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—APOA1—atherosclerosis	9.84e-06	0.000149	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—NOS3—atherosclerosis	9.67e-06	0.000147	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—NOS3—atherosclerosis	9.67e-06	0.000147	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PIK3CG—atherosclerosis	8.98e-06	0.000136	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PTGS2—atherosclerosis	8.85e-06	0.000134	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PTGS2—atherosclerosis	8.85e-06	0.000134	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PPARG—atherosclerosis	8.67e-06	0.000132	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—INS—atherosclerosis	8.5e-06	0.000129	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ALB—atherosclerosis	7.79e-06	0.000118	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—AKT1—atherosclerosis	7.74e-06	0.000118	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—NOS3—atherosclerosis	7.46e-06	0.000113	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PTGS2—atherosclerosis	6.82e-06	0.000104	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—AKT1—atherosclerosis	6.43e-06	9.77e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—AKT1—atherosclerosis	4.45e-06	6.75e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—AKT1—atherosclerosis	4.45e-06	6.75e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—AKT1—atherosclerosis	3.43e-06	5.2e-05	CbGpPWpGaD
